|
1
|
Kudo M: Immune checkpoint inhibition in
hepatocellular carcinoma: Basics and ongoing clinical trials.
Oncology. 92:50–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu S, Li A, Liu Q, Li T, Yuan X, Han X and
Wu K: Chimeric antigen receptor T cells: A novel therapy for solid
tumors. J Hematol Oncol. 10:782017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu L, Huang F, Wan T, Xu H and Zhao Q:
Overexpression of long noncoding RNA LINC00882 is associated with
poor prognosis in hepatocellular carcinoma. Onco Targets Ther.
11:5209–5217. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Y, Xiang B, Liu Y, Wang Y and Kan H:
LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human
hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Cancer
Lett. 437:56–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu Y, Luo X, He W, Chen G, Li Y, Li W,
Wang X, Lai Y and Ye Y: Long non-coding RNA PVT1/miR-150/HIG2 axis
regulates the proliferation, invasion and the balance of iron
metabolism of hepatocellular carcinoma. Cell Physiol Biochem.
49:1403–1419. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji D, Jiang C, Zhang L, Liang N, Jiang T,
Yang B and Liang H: LncRNA CRNDE promotes hepatocellular carcinoma
cell proliferation, invasion, and migration through regulating
miR-203/BCAT1 axis. J Cell Physiol. 234:6548–6560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang D, Bi C, Zhao Q, Ding X, Bian C,
Wang H, Wang T and Liu H: Knockdown long non-coding RNA ANRIL
inhibits proliferation, migration and invasion of HepG2 cells by
down-regulation of miR-191. BMC Cancer. 18:9192018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang XL, Shi M, Xiang T and Bu YZ: Long
noncoding RNA DGCR5 represses hepatocellular carcinoma progression
by inactivating Wnt signaling pathway. J Cell Biochem. 120:275–282.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang YG, Liu J, Shi M and Chen FX: LncRNA
DGCR5 represses the development of hepatocellular carcinoma by
targeting the miR-346/KLF14 axis. J Cell Physiol. 234:572–580.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong H, Ni Z, He J, Jiang S, Li X, He J,
Gong W, Zheng L, Chen S, Li B, et al: LncRNA HULC triggers
autophagy via stabilizing Sirt1 and attenuates the chemosensitivity
of HCC cells. Oncogene. 36:3528–3540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Booy EP, McRae EK, Howard R, Deo SR, Ariyo
EO, Dzananovic E, Meier M, Stetefeld J and McKenna SA: RNA helicase
associated with AU-rich element (RHAU/DHX36) interacts with the
3′-Tail of the long non-coding RNA BC200 (BCYRN1). J Biol Chem.
291:53552016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang XY, Zhang LX, Tian CJ, Tang XY, Zhao
LM, Guo YL, Cheng DJ, Chen XL, Ma LJ and Chen ZC: LncRNAs BCYRN1
promoted the proliferation and migration of rat airway smooth
muscle cells in asthma via upregulating the expression of transient
receptor potential 1. Am J Transl Res. 8:3409–3418. 2016.PubMed/NCBI
|
|
13
|
Booy EP, McRae EK, Koul A, Lin F and
McKenna SA: The long non-coding RNA BC200 (BCYRN1) is critical for
cancer cell survival and proliferation. Mol Cancer. 16:1092017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh R, Gupta SC, Peng WX, Zhou N,
Pochampally R, Atfi A, Watabe K, Lu Z and Mo YY: Regulation of
alternative splicing of Bcl-x by BC200 contributes to breast cancer
pathogenesis. Cell Death Dis. 7:e22622016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao
XG and Hu HY: BC200 LncRNA a potential predictive marker of poor
prognosis in esophageal squamous cell carcinoma patients. Onco
Targets Ther. 9:2221–2226. 2016.PubMed/NCBI
|
|
16
|
Hu T and Lu YR: BCYRN1, a c-MYC-activated
long non-coding RNA, regulates cell metastasis of non-small-cell
lung cancer. Cancer Cell Int. 15:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin YH, Wu MH, Huang YH, Yeh CT, Chi HC,
Tsai CY, Chuang WY, Yu CJ, Chung IH, Chen CY and Lin KH: Thyroid
hormone negatively regulates tumorigenesis through suppression of
BC200. Endocr Relat Cancer. 25:967–979. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ho TT, Zhou N, Huang J, Koirala P, Xu M,
Fung R, Wu F and Mo YY: Targeting non-coding RNAs with the
CRISPR/Cas9 system in human cell lines. Nucleic Acids Res.
43:e172015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cui X, Zhao C, Yao X, Qian B, Su C, Ren Y,
Yao Z, Gao X and Yang J: SND1 acts as an anti-apoptotic factor via
regulating the expression of lncRNA UCA1 in hepatocellular
carcinoma. RNA Biol. 2018:1–12. 2018.
|
|
23
|
Zhang YT, Li BP, Zhang B, Ma P, Wu QL,
Ming L and Xie LM: LncRNA SBF2-AS1 promotes hepatocellular
carcinoma metastasis by regulating EMT and predicts unfavorable
prognosis. Eur Rev Med Pharmacol Sci. 22:6333–6341. 2018.PubMed/NCBI
|
|
24
|
Lee YR, Kim G, Tak WY, Jang SY, Kweon YO,
Park JG, Lee HW, Han YS, Chun JM, Park SY and Hur K: Circulating
exosomal non-coding RNAs as prognostic biomarkers in human
hepatocellular carcinoma. Int J Cancer. 15:1444–1452. 2018.
|
|
25
|
Tiedge H, Chen W and Brosius J: Primary
structure, neural- specific expression, and dendritic location of
human BC200 RNA. J Neurosci. 13:2382–2390. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martignetti JA and Brosius J: BC200 RNA: A
neural RNA polymerase III product encoded by a monomeric Alu
element. Proc Natl Acad Sci USA. 90:11563–11567. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim Y, Lee J, Shin H, Jang S, Kim SC and
Lee Y: Biosynthesis of brain cytoplasmic 200 RNA. Sci Rep.
7:68842017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Bocker W, Brosius J and Tiedge H:
Expression of neural BC200 RNA in human tumours. J Pathol.
183:345–351. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shin H, Lee J, Kim Y, Jang S and Lee Y,
Kim S and Lee Y: Knockdown of BC200 RNA expression reduces cell
migration and invasion by destabilizing mRNA for calcium-binding
protein S100A11. RNA Biol. 14:1418–1430. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li P, Yang B, Xia SY, Chen L, Ning N, Ma
B, Liu Q, Yang H, Zhang D and Du XH: BC200 RNA is over-expressed in
colorectal cancer and promotes migration and invasion of HCT116
cells. Int J Clin Exp Pathol. 9:1481–1486. 2016.
|
|
31
|
Robson S, Pelengaris S and Khan M: C-Myc
and downstream targets in the pathogenesis and treatment of cancer.
Recent Pat Anticancer Drug Discov. 1:305–326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Opferman JT and Kothari A: Anti-apoptotic
BCL-2 family members in development. Cell Death Differ. 25:37–45.
2018. View Article : Google Scholar
|
|
33
|
de Jong Y, Monderer D, Brandinelli E,
Monchanin M, van den Akker BE, van Oosterwijk JG, Blay JY, Dutour A
and Bovée JVMG: Bcl-xl as the most promising Bcl-2 family member in
targeted treatment of chondrosarcoma. Oncogenesis. 7:742018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gu L, Lu L, Zhou D and Liu Z: Long
noncoding RNA BCYRN1 promotes the proliferation of colorectal
cancer cells via up-regulating NPR3 expression. Cell Physiol
Biochem. 48:2337–2349. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bergandi L, Mungo E, Morone R, Bosco O,
Rolando B and Doublier S: Hyperglycemia promotes chemoresistance
through the reduction of the mitochondrial DNA damage, the
Bax/Bcl-2 and Bax/Bcl-XL ratio, and the cells in sub-G1 phase due
to antitumoral drugs induced-cytotoxicity in human colon
adenocarcinoma cells. Front Pharmacol. 9:8662018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li M, Liu XH, Zhao YC, Ma XY, Zhou YC,
Zhao YX and Liu XY: Long noncoding RNA KCNQ1OT1 promotes apoptosis
in neuroblastoma cells by regulating miR-296-5p/Bax axis. FEBS J.
21:150472019. View Article : Google Scholar
|
|
37
|
Shao J, Pan X, Yin X, Fan G, Tan C, Yao Y,
Xin Y and Sun C: KCNQ1OT1 affects the progression of diabetic
retinopathy by regulating miR-1470 and epidermal growth factor
receptor. J Cell Physiol. 234:17269–17279. 2019. View Article : Google Scholar : PubMed/NCBI
|
